|
WO2013093629A2
|
|
Modular vaccines, methods and compositions related thereto
|
|
WO2012164398A2
|
|
Modulation of the ubiquitin-proteasome system (ups)
|
|
WO2012138789A2
|
|
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
AU2012240240A1
|
|
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
WO2012090073A2
|
|
Methods and compositions for predicting chemotherapy sensitivity
|
|
CA2569479A1
|
|
Combination comprising a bcrp inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
|
|
US2008187909A1
|
|
Classification of breast cancer patients using a combination of clinical criteria and informative genesets
|
|
US7171311B2
|
|
Methods of assigning treatment to breast cancer patients
|
|
EP1340080A2
|
|
Membrane molecule indicator compositions and methods
|
|
HU0002781A3
|
|
Methods of screening compounds useful for prevention of infection or pathogenicity
|
|
AU4784996A
|
|
Homologous recombination in mismatch repair inactivated eukaryotic cells
|
|
US4939081A
|
|
Cell-separation
|
